# Galvanize Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/galvanize-therapeutics

- Industry: Medical Devices & Equipment
- Headquarters: Redwood City, US
- Website: www.galvanizetx.com
- Total disclosed funding: $196M
- Latest round: Series C (Sep 3, 2025)
- Investors on record: 12

## About

Founded in 2015 by founder Jonathan Waldstreicher and based in California, US, Galvanize Therapeutics, Inc. develops energy-based medical devices to address a range of medical conditions, such as oncology, chronic bronchitis, and drug delivery. In September 2025, Galvanize Therapeutics, Inc. raised USD 100 million in series C funding led by investor Sofinnova Partners, with participation from other investors Norwest Venture Partners, Elevage Medical Technologies, LP, Ally Bridge Group, Perceptive Advisors, Janus Henderson Investors, Longaeva Partners, Fidelity Investments, T Rowe Price, Gilmartin Capital, Intuitive Surgical, Inc. and Apple Tree Partners. As of September 2025, the company is led by CEO Doug Godshall. Galvanize Therapeutics' primary product is the Aliya pulsed electric field system to enhance treatment efficacy in oncology and other therapeutic areas. The Aliya system is designed to provide a non-invasive approach for tissue ablation and modulation, improving patient outcomes in conditions such as non-small cell lung cancer (NSCLC) and chronic bronchitis. The company's product portfolio includes the INUMI Flex Endoscopic Needle, which is used in conjunction with the Aliya system for soft tissue ablation. The company will use the September 2025 funding to enhance the development of its oncology and medical solutions.

## Funding rounds

- Series C, Sep 3, 2025, $96M — Sofinnova Partners, T Rowe Price, Norwest Venture Partners, Apple Tree Partners, Fidelity Investments, Janus Henderson Investors, Intuitive Surgical, Inc., Ally Bridge Group, Perceptive Advisors, Gilmartin Capital, Elevage Medical Technologies, LP, Longaeva Partners
- Series B, Mar 29, 2022, $100M — Apple Tree Partners, Fidelity Investments, Intuitive Surgical, Inc., Gilmartin Capital

## Investors

- Apple Tree Partners (https://capitalatlas.ai/funds/apple-tree-partners) — Series B, Series C
- Fidelity Investments (https://capitalatlas.ai/funds/fidelity-investments) — Series B, Series C
- Intuitive Surgical, Inc. — Series B, Series C
- Gilmartin Capital (https://capitalatlas.ai/funds/gilmartin-capital) — Series B, Series C
- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Series C
- T Rowe Price (https://capitalatlas.ai/funds/t-rowe-price) — Series C
- Norwest Venture Partners (https://capitalatlas.ai/funds/norwest-venture-partners) — Series C
- Janus Henderson Investors — Series C
- Ally Bridge Group (https://capitalatlas.ai/funds/ally-bridge-group) — Series C
- Perceptive Advisors (https://capitalatlas.ai/funds/perceptive-advisors) — Series C
- Elevage Medical Technologies, LP — Series C
- Longaeva Partners — Series C